Cresco Labs Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CRLBF research report →
About the company
Cresco Labs Inc. engages in cultivating medical grade cannabis, manufacturing medical products derived from cannabis cultivation, and distributing such products to medical or adult use consumers. It focuses on regulatory compliance while working to develop condition-specific strains of cannabis and non-invasive delivery methods.
- CEO
- Charles Bachtell
- IPO
- 2018
- Employees
- 2,826
- HQ
- Chicago, IL, US
Price Chart
- Market Cap
- $290.46M
- P/E
- -2.06
- P/S
- 0.45
- P/B
- 0.89
- EV/EBITDA
- 7.54
- Div Yield
- 0.00%
- Gross Margin
- 48.57%
- Op Margin
- 10.41%
- Net Margin
- -21.28%
- ROE
- -35.26%
- ROIC
- 5.92%
- Revenue
- $667.33M · -7.87%
- Net Income
- $-137,778,389 · -85.09%
- EPS
- $-0.39 · -77.27%
- Op Income
- $99.08M
- FCF YoY
- -64.76%
- 52W High
- $2.30
- 52W Low
- $0.47
- 50D MA
- $0.92
- 200D MA
- $1.04
- Beta
- 1.72
- Avg Volume
- 743.91K
Get TickerSpark's AI analysis on CRLBF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our CRLBF coverage
Recent articles, reports, and earnings notes.
No research on CRLBF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CRLBF report →Similar companies
Peers in the same neighborhood.